
Sign up to save your podcasts
Or


We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease
By Sensible Medicine Authors and Editors4.9
135135 ratings
We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease

32,246 Listeners

4,270 Listeners

1,877 Listeners

549 Listeners

504 Listeners

906 Listeners

2,455 Listeners

3,374 Listeners

1,150 Listeners

8,043 Listeners

755 Listeners

518 Listeners

739 Listeners

437 Listeners

8,447 Listeners